Skip to main content
有効成分食品原料

ナットウキナーゼ

Nattokinase (Natto Kinase)

国内調達のメリット

Sourced from Nationwide (production hubs in Osaka, Kyoto, Oita) with year-round Japanese supply, consistent quality, and traceability to the prefecture of origin.

主要スペック

Serine protease from Bacillus subtilis var. natto source; FFC notification(s) on file; MOQ from 100 g – 10 kg (concentrated powder).

代表的な完成品

Cardiovascular-positioned supplements (capsules) — Smooth blood flow under FFC where notified.

ひと目で分かる

登録サプライヤー数
2 社のサプライヤー
標準 MOQ
100 g – 10 kg (concentrated powder)
標準リードタイム
4-6 weeks
産地
Nationwide (production hubs in Osaka, Kyoto, Oita)
カテゴリ
食品原料
価格帯
140,000-180,000 JPY/kg
国内法規ステータス
FFC-accepted for smooth blood flow
日本語名
ナットウキナーゼ
ローマ字
Natto Kinase

本原料について

1980 年に須見洋行博士が発見した、納豆菌による大豆発酵から得られる線維素溶解酵素。

法規ステータス

日本FFC-accepted for smooth blood flow
EUFood supplement; novel food assessment may apply
米国Dietary supplement under DSHEA

OEM バイヤー向け FAQ

Q. What MOQ is typical for high-activity nattokinase concentrate?

Typical MOQs range from 100 g (for R&D) to 10 kg (production), with bulk lots available on request.

出典

  • Source dossier (provided)

業界知見 — 単一の一次情報源は未確定

Q. What activity level is required for the JNKA mark?

JNKA-certified products require at least 2,000 FU per recommended daily dose, alongside vitamin K2 removal and other quality criteria.

Q. Why is vitamin K2 removed from many commercial preparations?

Vitamin K2 removal addresses formulation compatibility with consumers on warfarin-type anticoagulants, which interact with vitamin K. Suppliers offer K2-reduced grades; clinical precaution remains advised.

Q. Can nattokinase be sold as a dietary supplement in the US?

Nattokinase is sold in the US dietary supplement channel under DSHEA. Manufacturers and importers remain responsible for safety substantiation and labeling compliance.

Q. What documents should buyers request from a Japanese nattokinase supplier?

Standard requests include: COA with FU activity, JNKA certification status, vitamin K2 content, allergen statement (soy), GMO/non-GMO statement on substrate, and fermentation strain documentation.

出典

  • Source dossier (provided)

業界知見 — 単一の一次情報源は未確定

活用事例

  • Cardiovascular-positioned supplements (capsules)

    ポジショニング
    Smooth blood flow under FFC where notified
    典型配合率
    ≥2,000 FU per daily dose for JNKA-certified products
    配合上の注意
    Enteric coating common; protect from heat and humidity
  • FFC functional foods

    ポジショニング
    Smooth blood flow positioning
    配合上の注意
    Endpoint wording must mirror individual FFC notification
  • Export supplements (US/EU/Asia)

    ポジショニング
    Cardiovascular wellness — non-disease, non-drug claims only
    配合上の注意
    Verify EU novel-food status of the specific extract; localize labeling

国内サプライヤー

Nattokinase について問い合わせる